Browse by category

Metabolic surgery on patients with heart failure can result in a reduction in the need for oral diuretics, which are used to manage...

Patients on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - Victoza (Liraglutide 1.8mg), Saxenda (Liraglutide 3mg), Ozempic...

The majority of participants experience changes in taste perception, desire, and enjoyment of flavours after undergoing sleeve...

Hanmi Pharm has announced promising research results for its novel obesity treatment, HM17321. According to the company, this...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Omada Health has released findings from an attitudinal survey of 1,000 non-Omada members to better understand the needs of consumers...

Cytoki Pharma has announced the first patient has received CK-0045 in a Phase 2 proof-of-concept trial evaluating efficacy, safety and...

Endevica Bio is to spin-off of a newly created company called Abisati to develop an oral weight loss treatment that has shown efficacy in...

Results from STEP 9 phase 3 clinical trial shows that studied semaglutide 2.4mg, compared to placebo as an adjunct to lifestyle...

Palatin Technologies has completed enrolment in the study entitled "BMT-801, A Phase II, Randomized, Double-Blind, Placebo-Controlled,...